Cost–effectiveness of alternative NTRK testing strategies in cancer patients followed by histology-independent therapy with entrectinib: an analysis of three European countries

Personalized Medicine

Oct 30

Written by Matthijs Versteegh

Oncologypersonalized medicine

Matthijs Versteegh

Effectiveness of Seizure Dogs for People With Severe Refractory Epilepsy Results From the EPISODE Study

Benefits of sphingosine-1-phosphate receptor modulators in relapsing MS estimated with a treatment sequence model